Additional file 1 of A combination of PD-1 and TIGIT immune checkpoint inhibitors elicits a strong anti-tumour response in mesothelioma

Institutions

University of Technology Sydney (AU)
The University of Sydney (AU)
Garvan Institute of Medical Research (AU)
Victor Chang Cardiac Research Institute (AU)
Royal Prince Alfred Hospital (AU)
UNSW Sydney (AU)
Chris O’Brien Lifehouse (AU)
Anzac Research Institute (AU)

Publication Details

Journal: Figshare
Published: 2025-01-01
DOI: https://doi.org/10.6084/m9.figshare.28406278.v1
Primary Topic: Cancer Immunotherapy and Biomarkers
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Additional file 1 of A combination of PD-1 and TIGIT immune checkpoint inhibitors elicits a strong anti-tumour response in mesothelioma

Jan 1, 2025

Figshare

Cancer Immunotherapy and Biomarkers

article

Additional file 1 of A combination of PD-1 and TIGIT immune checkpoint inhibitors elicits a strong anti-tumour response in mesothelioma

January 1, 2025article en

Abstract

No abstract available for this paper.

Figshare

University of Technology Sydney (AU), The University of Sydney (AU), Garvan Institute of Medical Research (AU), Victor Chang Cardiac Research Institute (AU), Royal Prince Alfred Hospital (AU), UNSW Sydney (AU), Chris O’Brien Lifehouse (AU), Anzac Research Institute (AU)

Zero hunger

Openalex Percentile: Top 39%

Cancer Immunotherapy and Biomarkers

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.